search
Back to results

A Community Pharmacy-based Program to Improve Management of Diabetes

Primary Purpose

Diabetes Mellitus, Type 2

Status
Completed
Phase
Not Applicable
Locations
Iran, Islamic Republic of
Study Type
Interventional
Intervention
Community pharmacist-led diabetes education program
Usual care
Sponsored by
Tehran University of Medical Sciences
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Diabetes Mellitus, Type 2 focused on measuring Community Pharmacy Services, Pharmacists, Diabetes Mellitus, Diabetes Mellitus, Type 2, Self Care, Randomized Controlled Trial

Eligibility Criteria

undefined - undefined (Child, Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Type 2 diabetic patients using oral anti diabetic medications.
  • Hemoglobin A1c > 7 within the previous month before recruitment
  • Adequate literacy and ability to use the glucometer.
  • Signing the informed consent

Exclusion Criteria:

  • Patients requiring adjunct insulin therapy.
  • Patients with concurrent heart failure (stage 4).
  • Patients who fast in Ramadan.
  • Patients receiving diabetes education in other programs.

Sites / Locations

  • Taleghani Community Pharmacy, Faculty of Pharmacy, Tehran University of Medical Sciences

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Community Pharmacy-based Program

Usual care

Arm Description

Outcomes

Primary Outcome Measures

Hemoglobin A1c
Hemoglobin A1c is measured in all patients prior to participating in the study. All patients will be required to take the test again at the end of the study (6 months) .

Secondary Outcome Measures

Medication adherence
Medication adherence will be measured using "Morisky Medication Adherence Questionnaire" which will be translated into Farsi.The validity and reliability of the translated questionnaire will be investigated primarily.
Self-care activity
Self-care activity will be measured using "Diabetes Self-care Activity Measure" questionnaire which will be translated into Farsi. We will investigate the validity and reliability of the translated questionnaire.
Body Mass Index
Weight (measured in kilograms) divided by square of height (measured in Meters).
Blood pressure

Full Information

First Posted
January 31, 2012
Last Updated
April 16, 2014
Sponsor
Tehran University of Medical Sciences
Collaborators
Research Center for Rational Use of Drugs
search

1. Study Identification

Unique Protocol Identification Number
NCT01525992
Brief Title
A Community Pharmacy-based Program to Improve Management of Diabetes
Official Title
A Community Pharmacy-based Intervention on Type 2 Diabetic Patients to Improve Medications Adherence and Disease Outcomes; a Randomized Controlled Trial.
Study Type
Interventional

2. Study Status

Record Verification Date
April 2014
Overall Recruitment Status
Completed
Study Start Date
March 2012 (undefined)
Primary Completion Date
August 2013 (Actual)
Study Completion Date
September 2013 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Tehran University of Medical Sciences
Collaborators
Research Center for Rational Use of Drugs

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
In this study the investigators aim to evaluate the impact of a community pharmacy-based program to educate type 2 diabetic patients about medications, life style and self-care.
Detailed Description
Diabetes mellitus type 2 is a progressive metabolic disorder that leads to several morbidities and increased mortality and costs. Studies showed that strict control of blood glucose in diabetic patients reduces patients' risk of microvascular complications. Community pharmacies are a well-placed healthcare facility located at the heart of the community with convenient access to pharmacists as health care professionals. Some studies have shown effective interventions led by community and clinical pharmacist in developed countries. In developing countries, little evidence exists about feasibility of implementing community pharmacy-based services to promote medications adherence, self glucose monitoring and self-care in diabetic patients. This study is a 2 arm randomized controlled trial. Eligible patients are referred to the community pharmacy from an endocrinologist's office. Of 135 type-2 diabetic patients who will be recruited in the study,68 will be randomly allocated to the intervention arm using telephone balanced blocked randomization method. A community pharmacy-based program will provide training about medications, life style and self-care to the intervention arm. The control arm (67 patients) will receive usual care during the study period. The primary outcome of this study is measured as change in hemoglobin A1C pre and post intervention. As the secondary outcome, medications adherence, diabetes self-care activity, body mass index and blood pressure are measured.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Diabetes Mellitus, Type 2
Keywords
Community Pharmacy Services, Pharmacists, Diabetes Mellitus, Diabetes Mellitus, Type 2, Self Care, Randomized Controlled Trial

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
101 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Community Pharmacy-based Program
Arm Type
Experimental
Arm Title
Usual care
Arm Type
Active Comparator
Intervention Type
Behavioral
Intervention Name(s)
Community pharmacist-led diabetes education program
Intervention Description
A trained pharmacist will counsel each patient based on his/her individual needs about medications, life style and self-care. The pharmacist will use a checklist to document the type of education delivered to each patient. A glucometer is provided for each patient in this arm to monitor blood glucose daily. Three to six visits to the community pharmacy are set during the 6-months study period. At each visit, medication related problems and self-care issues are discussed with the patient and the glucometer test strips are provided for the following month. A telephone call will be made to each patient between visits to ensure adherence to drug therapy and resolve any problems .
Intervention Type
Other
Intervention Name(s)
Usual care
Intervention Description
The baseline and 6-month follow-up visits to the community pharmacy will be required. If the physician prefers more visits to his office during the study period, it will be granted. The glucometer and a training session about diabetes self-care will be provide at the end of study for control group patients.
Primary Outcome Measure Information:
Title
Hemoglobin A1c
Description
Hemoglobin A1c is measured in all patients prior to participating in the study. All patients will be required to take the test again at the end of the study (6 months) .
Time Frame
Change from baseline (at the point of recruiting) Hemoglobin A1c at 6 months.
Secondary Outcome Measure Information:
Title
Medication adherence
Description
Medication adherence will be measured using "Morisky Medication Adherence Questionnaire" which will be translated into Farsi.The validity and reliability of the translated questionnaire will be investigated primarily.
Time Frame
Change from baseline (at the point of recruiting) medication adherence at 6 months.
Title
Self-care activity
Description
Self-care activity will be measured using "Diabetes Self-care Activity Measure" questionnaire which will be translated into Farsi. We will investigate the validity and reliability of the translated questionnaire.
Time Frame
Change from baseline (at the point of recruiting) Self-care activity at 6 months.
Title
Body Mass Index
Description
Weight (measured in kilograms) divided by square of height (measured in Meters).
Time Frame
Change from baseline (at the point of recruiting) Body Mass Index at 6 months.
Title
Blood pressure
Time Frame
Change from baseline (at the point of recruiting) Blood pressure at 6 months.

10. Eligibility

Sex
All
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Type 2 diabetic patients using oral anti diabetic medications. Hemoglobin A1c > 7 within the previous month before recruitment Adequate literacy and ability to use the glucometer. Signing the informed consent Exclusion Criteria: Patients requiring adjunct insulin therapy. Patients with concurrent heart failure (stage 4). Patients who fast in Ramadan. Patients receiving diabetes education in other programs.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Kheirollah Gholami, M.Sc, PharmD
Organizational Affiliation
Tehran University of Medical Sciences
Official's Role
Study Chair
First Name & Middle Initial & Last Name & Degree
Zahra Jahangard-Rafsanjani, PharmD
Organizational Affiliation
Tehran University of Medical Sciences
Official's Role
Study Director
First Name & Middle Initial & Last Name & Degree
Arash Rashidian, MD, Ph.D
Organizational Affiliation
Tehran University of Medical Sciences
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Navid Saadat, MD
Organizational Affiliation
Shahid Beheshti University of Medical Sciences
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Amir Sarayani, PharmD, MPH
Organizational Affiliation
Tehran University of Medical Sciences
Official's Role
Principal Investigator
Facility Information:
Facility Name
Taleghani Community Pharmacy, Faculty of Pharmacy, Tehran University of Medical Sciences
City
Tehran
Country
Iran, Islamic Republic of

12. IPD Sharing Statement

Learn more about this trial

A Community Pharmacy-based Program to Improve Management of Diabetes

We'll reach out to this number within 24 hrs